p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Volume -, Issue -, Pages ijgc-2020-002256
Publisher
BMJ
Online
2021-02-16
DOI
10.1136/ijgc-2020-002256
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification
- (2020) Soyoun Rachel Kim et al. GYNECOLOGIC ONCOLOGY
- Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
- (2020) Vicky Makker et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis
- (2020) Amanda N. Fader et al. CLINICAL CANCER RESEARCH
- BRCA 1/2 Somatic Mutations in Patients with Advanced or Recurrent Endometrial Cancer
- (2020) J. Fehniger et al. GYNECOLOGIC ONCOLOGY
- Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study
- (2020) Britt K. Erickson et al. GYNECOLOGIC ONCOLOGY
- Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
- (2020) Alicia León-Castillo et al. JOURNAL OF CLINICAL ONCOLOGY
- LBA36 Safety and antitumor activity of dostarlimab in patients (pts) with advanced or recurrent DNA mismatch repair deficient (dMMR) or proficient (MMRp) endometrial cancer (EC): Results from GARNET
- (2020) A. Oaknin et al. ANNALS OF ONCOLOGY
- A phase II trial of the Wee1 inhibitor adavosertib (AZD1775) in recurrent uterine serous carcinoma
- (2020) J.F. Liu et al. GYNECOLOGIC ONCOLOGY
- PROGNOSTIC INTEGRATED IMAGE-BASED IMMUNE AND MOLECULAR PROFILING IN EARLY-STAGE ENDOMETRIAL CANCER
- (2020) Nanda Horeweg et al. Cancer Immunology Research
- HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes
- (2020) Lisa Vermij et al. Cancers
- Impact of TP53 immunohistochemistry on the histological grading system for endometrial endometrioid carcinoma
- (2019) Mitsutake Yano et al. MODERN PATHOLOGY
- Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapy
- (2019) Emily N. Prendergast et al. GYNECOLOGIC ONCOLOGY
- Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer
- (2019) Panagiotis A. Konstantinopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study
- (2019) Pamela T. Soliman et al. CLINICAL CANCER RESEARCH
- p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies
- (2019) Naveena Singh et al. JOURNAL OF PATHOLOGY
- Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
- (2019) Alicia León‐Castillo et al. JOURNAL OF PATHOLOGY
- Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups
- (2018) Tjalling Bosse et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
- (2018) S Kommoss et al. ANNALS OF ONCOLOGY
- An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer
- (2018) Casey M. Cosgrove et al. GYNECOLOGIC ONCOLOGY
- Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas
- (2018) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu
- (2018) Amanda N. Fader et al. JOURNAL OF CLINICAL ONCOLOGY
- Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
- (2018) Marthe M. de Jonge et al. CLINICAL CANCER RESEARCH
- Cancer susceptibility gene mutations in type I and II endometrial cancer
- (2018) Beverly Long et al. GYNECOLOGIC ONCOLOGY
- Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression
- (2018) Charles W. Ashley et al. GYNECOLOGIC ONCOLOGY
- Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study
- (2017) Patrick A. Ott et al. JOURNAL OF CLINICAL ONCOLOGY
- The genetic landscape of endometrial clear cell carcinomas
- (2017) Deborah F DeLair et al. JOURNAL OF PATHOLOGY
- Interobserver Variability in the Diagnosis of Uterine High-Grade Endometrioid Carcinoma
- (2016) Sumi Thomas et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
- (2016) Ellen Stelloo et al. CLINICAL CANCER RESEARCH
- A clinically applicable molecular-based classification for endometrial cancers
- (2015) A Talhouk et al. BRITISH JOURNAL OF CANCER
- Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
- (2015) Brian M. Slomovitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
- (2015) Ellen Stelloo et al. MODERN PATHOLOGY
- Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma
- (2013) C. Blake Gilks et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Use of mutation profiles to refine the classification of endometrial carcinomas
- (2012) Melissa K McConechy et al. JOURNAL OF PATHOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started